📰 Peter Denardo News
Page 2 - Peter Denardo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Denardo. Real-time updates on events, politics, business and more.
December 29, 2023
SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to...
December 29, 2023
SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 -- Standard BioTools Inc. , driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that a second...
December 23, 2023
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 -- Standard BioTools Inc. , driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health - today announced that leading...
December 8, 2023
Investegate announcements from Directorate Change
November 14, 2023
14.11.2023 - LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved ...
November 8, 2023
Operator: Hello, and welcome to the Standard BioTools Third Quarter 2023 Financial Results Conference Call. As a reminder this conference is being recorded.
November 7, 2023
07.11.2023 - Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectivesPlanned merger with SomaLogic activates strategic M&A thesis SOUTH SAN FRANCISCO, Calif., Nov. ...
November 2, 2023
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to...
October 25, 2023
SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to...
October 6, 2023
LONDON and SALT LAKE CITY, Oct. 06, 2023 -- Renalytix plc , the first company to commercialize an FDA authorized artificial intelligence enabled blood test to assess risk of progressive kidney...